The marijuana industry is seeing green.
Not only has the cannabis story disrupted alcohol, cigarettes, food, pharmaceuticals, and the global wellness industry. Even major retailers are jumping on board, seeing incredible opportunities for growth.
Just last week, even a new ETF was launched.
Advisor Shares Pure Cannabis ETF (YOLO)
YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace, notes AdvisorShares.
Already included in the ETF are stocks such as Green Organic Dutchman Holdings, Supreme Cannabis, Aurora Cannabis, Tilray Inc., Canopy Growth, Aleafia Health, WeedMD, Khiron Life Sciences, and Village Farm International.
Now, a newer cannabis ETF has been launched in the U.S.
Years ago, Horizons introduced the first cannabis ETF, the Horizons Marijuana Life Sciences ETF (HMLSF). With an expense ratio of 0.75% a year, an investor can diversify with some of the top industry names. The best part – an invest of $10,000 would have doubled just over the last two years. Cannabis growth is that explosive.
Now, Horizons has launched the first-ever U.S. focused cannabis ETF, the Horizons U.S. Marijuana Index ETF, which trades in Canada under the symbol, “HMUS.” It should soon trade here in the U.S., as well if you’re interested in taking part in this ETF.
At the moment, the new ETF holds 32 U.S. focused cannabis stocks, including Curaleaf Holdings (CURLF), Cresco Labs (CRLBF), Charlotte’s Web Holdings (CWBHF), MedMen Enterprises (MMNFF), Green Thumb Industries (GTBIF), Acreage Holdings (ACRGF), iAnthus Capital Holdings (ITHUF), Green Growth Brands (GGBXF), and Harvest Health & Recreation (HRVSF) just to name a few.
Here’s the beauty of such an ETF.
At the moment, the new ETF trades just under $8 a share. If we wanted to buy 100 shares, it would cost us $800 to diversify among some of the top industry names.
If we wanted to buy 100 shares of each of the above-mentioned stocks all at once, it would cost us thousands of dollars. And we wouldn’t be afforded the same diversification.